Expedition Therapeutics is a startup based in the United States, most recent round Series A, 1 tracked investor.
Expedition Therapeutics is a startup founded in 2023 based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Expedition Therapeutics is a biotech company developing novel therapies for serious inflammatory and respiratory diseases, with a focus on targeting neutrophilic inflammation in chronic obstructive pulmonary disease (COPD) through its lead candidate, EXPD-101, a DPP1 inhibitor.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.